Precision Medicine

Single-Cell CRISPR Assays Market Poised to Surpass $1 Billion by 2028

Researchers can now pinpoint how individual cells respond to gene edits, a capability previously impossible with bulk sequencing, unlocking a new era of precision medicine, according to Cell Journal .